Browse
Explore conditions, clinical trials, and the organisations running them.
7285 conditions with clinical trials.
- Lobular neoplasia 2644 trials
- Malignant mesothelioma 2644 trials
- Nasal cavity adenocarcinoma 2644 trials
- Nasal cavity cancer 2644 trials
- Retroperitoneal leiomyosarcoma 2644 trials
- SMARCA4-deficient sarcoma of thorax 2644 trials
- External ear carcinoma 2643 trials
- Gastroesophageal adenocarcinoma 2642 trials
- Invasive lobular breast carcinoma 2642 trials
- Dermatofibrosarcoma protuberans 2641 trials
- Iris melanoma 2641 trials
- Large cell carcinoma 2641 trials
- Malignant pleural mesothelioma 2641 trials
- Orbital cancer 2641 trials
- Orbit lymphoma 2641 trials
- Peritoneal carcinomatosis 2641 trials
- Spinal cord cancer 2641 trials
- Adult oligodendroglioma 2640 trials
- Embryonal rhabdomyosarcoma 2640 trials
- Extraskeletal Ewing sarcoma 2640 trials
- Malignant conjunctival melanoma 2640 trials
- Obesity disorder 2640 trials
- Pleomorphic liposarcoma 2640 trials
- Adrenal cortex carcinoma 2639 trials
- Extraskeletal myxoid chondrosarcoma 2639 trials
- Posterior uveal melanoma 2639 trials
- Round cell liposarcoma 2639 trials
- Skin basal cell carcinoma 2639 trials
- Small size posterior uveal melanoma 2639 trials
- Spinal cord glioma 2639 trials
- Spindle cell rhabdomyosarcoma 2639 trials
- Well-differentiated liposarcoma 2639 trials
- Botryoid rhabdomyosarcoma 2638 trials
- Conjunctival cancer 2638 trials
- Intimal sarcoma 2638 trials
- Iris cancer 2638 trials
- Low grade fibromyxoid sarcoma 2638 trials
- Medium/large size posterior uveal melanoma 2638 trials
- Pleomorphic rhabdomyosarcoma 2638 trials
- Testis rhabdomyosarcoma 2638 trials
- Testis sarcoma 2638 trials
- Undifferentiated round cell sarcoma 2638 trials
- Familial medullary thyroid carcinoma 2637 trials
- IDH-wildtype anaplastic astrocytoma 2637 trials
- Ocular melanoma with extraocular extension 2637 trials
- Oligodendroglioma, IDH-mutant and 1p/19q-codeleted grade 2 2637 trials
- Posterior fossa ependymoma 2637 trials
- Triple-positive breast carcinoma 2637 trials
- Classical glioblastoma 2636 trials
- Conventional fibrosarcoma 2636 trials